Coleman Mark bought AXSM
February 23, 2026 · Form 4 insider transaction
Coleman Mark bought 6,250 shares of Axsome Therapeutics, Inc. at $4.95 per share, a transaction worth $30.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,250
Price
$4.95
Total value
$30.9K
InsiderColeman Mark
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 23, 2026
Filing dateFebruary 25, 2026
Shares owned after72,140
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares.